122 related articles for article (PubMed ID: 8018376)
1. Relationship of DNA ploidy and S-phase fraction to survival after first recurrence of breast cancer.
Stål O; Carstensen JM; Wingren S; Rutqvist LE; Skoog L; Klintenberg C; Nordenskjöld B
Acta Oncol; 1994; 33(4):423-9. PubMed ID: 8018376
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.
Yokoe T; Izuo M; Ishida T; Iino Y; Kawai T
Jpn J Surg; 1990 Sep; 20(5):491-7. PubMed ID: 2243441
[TBL] [Abstract][Full Text] [Related]
3. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
Winter K; Eidtmann H; Jonat W
Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
[TBL] [Abstract][Full Text] [Related]
4. Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group.
Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
Int J Cancer; 1992 Apr; 51(1):28-33. PubMed ID: 1563841
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer.
Balslev I; Christensen IJ; Rasmussen BB; Larsen JK; Lykkesfeldt AE; Thorpe SM; Rose C; Briand P; Mouridsen HT
Int J Cancer; 1994 Jan; 56(1):16-25. PubMed ID: 8262673
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.
Ewers SB; Attewell R; Baldetorp B; Borg A; Fernö M; Långström E; Killander D
Breast Cancer Res Treat; 1992; 24(2):115-26. PubMed ID: 8443399
[TBL] [Abstract][Full Text] [Related]
9. S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer.
Wingren S; Stål O; Sullivan S; Brisfors A; Nordenskjöld B
Int J Cancer; 1994 Oct; 59(1):7-10. PubMed ID: 7523314
[TBL] [Abstract][Full Text] [Related]
10. Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients.
Stål O; Carstensen J; Hatschek T; Nordenskjöld B
Br J Cancer; 1992 Oct; 66(4):706-11. PubMed ID: 1419611
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.
Fernö M; Baldetorp B; Borg A; Olsson H; Sigurdsson H; Killander D
Acta Oncol; 1992; 31(2):157-65. PubMed ID: 1622630
[TBL] [Abstract][Full Text] [Related]
12. Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.
Lipponen P; Eskelinen M; Papinaho S; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
Anticancer Res; 1992; 12(3):677-82. PubMed ID: 1622125
[TBL] [Abstract][Full Text] [Related]
13. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.
Stål O; Wingren S; Carstensen J; Rutqvist LE; Skoog L; Klintenberg C; Nordenskjöld B
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):301-9. PubMed ID: 2702984
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.
Wenger CR; Beardslee S; Owens MA; Pounds G; Oldaker T; Vendely P; Pandian MR; Harrington D; Clark GM; McGuire WL
Breast Cancer Res Treat; 1993 Oct; 28(1):9-20. PubMed ID: 8123871
[TBL] [Abstract][Full Text] [Related]
16. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer.
Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
Int J Clin Oncol; 2001 Aug; 6(4):177-82. PubMed ID: 11706555
[TBL] [Abstract][Full Text] [Related]
18. DNA content flow cytometry as a prognostic factor for node-positive breast cancer. The role of multiparameter ploidy analysis and specimen sonication.
Witzig TE; Gonchoroff NJ; Therneau T; Gilbertson DT; Wold LE; Grant C; Grande J; Katzmann JA; Ahmann DL; Ingle JN
Cancer; 1991 Oct; 68(8):1781-8. PubMed ID: 1913523
[TBL] [Abstract][Full Text] [Related]
19. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy and S-phase fraction in primary breast carcinomas in relation to prognostic factors and survival for premenopausal patients at high risk for recurrent disease.
Lykkesfeldt AE; Balslev I; Christensen IJ; Larsen JK; Mølgaard H; Rasmussen BB; Thorpe S; Rose C
Acta Oncol; 1988; 27(6A):749-56. PubMed ID: 3219225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]